Streetbeat News

Stock Prices

CYTO

Altamira Therapeutics has published preclinical data showing that their SemaPhore nanoparticles delivering SOD2 mRNA significantly reduce aorta dilation, delay rupture, and lower mortality in an animal model of abdominal aortic aneurysm. The positive outcomes suggest potential use in managing small abdominal aortic aneurysms and preventing ruptures.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 1:03 pm

KREF

Four analysts have recently published ratings on KKR Real Estate Finance (NYSE:KREF), ranging from bullish to indifferent. The average 12-month price target is $10.69, with a high of $12.00 and a low of $9.50. Recent financial metrics indicate challenges in revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 1:01 pm

VIRT

In the last three months, 6 analysts have published ratings on Virtu Financial (NASDAQ:VIRT), with a mix of bullish, somewhat bullish, and indifferent perspectives. The average 12-month price target has increased to $24.62 from $21.12. Analysts from firms like Piper Sandler, UBS, Goldman Sachs, Citigroup, JP Morgan, and B of A Securities have raised their price targets and ratings for VIRT.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 1:01 pm

RITM

Analysts have provided mixed ratings for Rithm Capital (NYSE:RITM) over the past quarter, with a notable increase in the average 12-month price target from $11.90 to $12.9. The company's financial performance shows strong revenue growth and net margins, but a high debt-to-equity ratio indicates financial risk.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 1:01 pm

ARM

Over the past three months, 8 analysts have shared their insights on ARM Holdings (NASDAQ:ARM), with ratings ranging from bullish to bearish. The average 12-month price target has increased by 23.25% to $151.75. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments related to ARM Holdings.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 1:00 pm

SNV

Synovus Financial Corp (NYSE: SNV) has been analyzed by 12 analysts, showing a range of sentiments from bullish to bearish. Recent evaluations indicate a slight increase in the average 12-month price target to $43.25. Analysts have adjusted their ratings and price targets, reflecting their responses to Synovus Finl's market performance and financial challenges.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 1:00 pm

AAL

AAPL

AIPI

CIBR

CRWD

DAL

LRNZ

MSFT

OKTA

PANW

UAL

CrowdStrike's Falcon platform update caused a global tech outage affecting Microsoft systems, leading to significant disruptions in various sectors. CrowdStrike's stock dropped sharply, while competitors like SentinelOne, Palo Alto Networks, and Okta saw gains. ETFs and hedge funds with significant exposure to CrowdStrike were also impacted.

Portfolio Pulse from Piero Cingari

July 19, 2024 | 12:53 pm

Home Depot has reported a global cyber outage that has impacted some of its systems. Despite this, the company's stores and website remain operational.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:51 pm

HAL

Halliburton expects a recovery in natural gas activity by 2025, as discussed in their recent conference call.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:45 pm

HAL

Halliburton projects a 10% revenue growth in its international business for the full year, while expecting a 6-8% year-over-year decline in North America revenue.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:44 pm